Next Article in Journal
RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5
Next Article in Special Issue
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
Previous Article in Journal
Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pleomorphic Lobular Breast Carcinoma
Previous Article in Special Issue
Post-Operative Medium- and Long-Term Endocrine Outcomes in Patients with Non-Functioning Pituitary Adenomas—Machine Learning Analysis
 
 
Review

Article Versions Notes

Cancers 2023, 15(11), 2896; https://doi.org/10.3390/cancers15112896
Action Date Notes Link
article xml file uploaded 24 May 2023 14:14 CEST Original file -
article xml uploaded. 24 May 2023 14:14 CEST Update -
article pdf uploaded. 24 May 2023 14:14 CEST Version of Record https://www.mdpi.com/2072-6694/15/11/2896/pdf-vor
article html file updated 24 May 2023 14:15 CEST Original file -
article xml file uploaded 25 May 2023 04:42 CEST Update -
article xml uploaded. 25 May 2023 04:42 CEST Update https://www.mdpi.com/2072-6694/15/11/2896/xml
article pdf uploaded. 25 May 2023 04:42 CEST Updated version of record https://www.mdpi.com/2072-6694/15/11/2896/pdf
article html file updated 25 May 2023 04:43 CEST Update https://www.mdpi.com/2072-6694/15/11/2896/html
Back to TopTop